Comments on: LEO Pharma announces more than half of patients on Kyntheum® (brodalumab) maintain consistent levels of complete skin clearance for more than two years

Comments on: LEO Pharma announces more than half of patients on Kyntheum® (brodalumab) maintain consistent levels of complete skin clearance for more than two years https://www.novumpr.nl/2017/09/14/leo-pharma-announces-more-than-half-of-patients-on-kyntheum-brodalumab-maintain-consistent-levels-of-complete-skin-clearance-for-more-than-two-years/?utm_source=rss&utm_medium=rss&utm_campaign=leo-pharma-announces-more-than-half-of-patients-on-kyntheum-brodalumab-maintain-consistent-levels-of-complete-skin-clearance-for-more-than-two-years NovumPR press releases Thu, 14 Sep 2017 16:10:14 +0000 hourly 1 https://wordpress.org/?v=6.8.3